Literature DB >> 16732019

Hyperinsulinemia in cord blood in mothers with type 2 diabetes and gestational diabetes mellitus in New Zealand.

Jenny A Westgate1, Robert S Lindsay, Judith Beattie, Neil S Pattison, Greg Gamble, Lindsay F J Mildenhall, Bernhard H Breier, Frank D Johnstone.   

Abstract

OBJECTIVE: In genetically diabetes-prone populations, maternal diabetes during pregnancy increases the risk of their children developing diabetes and obesity (the vicious cycle of type 2 diabetes). Fetal hyperinsulinemia at birth acts as a marker of this risk. We therefore examined whether cord insulin and leptin concentrations are increased in offspring of Maori and Pacific Island mothers with type 2 and gestational diabetes mellitus (GDM) and varying degrees of glycemic control (HbA(1c)). RESEARCH DESIGNS AND METHODS: Maori and Pacific Island mothers were prospectively recruited at Middlemore Hospital, South Auckland. Cord blood was taken from umbilical vein at birth from singleton babies born after 32 weeks of gestation to 138 mothers with GDM, 39 mothers with type 2 diabetes, and 95 control mothers.
RESULTS: Babies born to mothers with both type 2 diabetes and GDM had higher birth weight and skinfold thickness and markedly higher concentrations of insulin (median [interquartile range] type 2 diabetes 77 pmol/l [42-143], GDM 67 pmol/l [42-235], and control subjects 33 pmol/l [18-62]; P < 0.001) and leptin (type 2 diabetes 39 ng/ml [18-75], GDM 31 ng/ml [17-58], and control subjects 13 ng/ml [8-22]; P < 0.001) in cord blood. Cord insulin concentrations >120 pmol/l were found in 29% of offspring of mothers with GDM and 31% of mothers with type 2 diabetes. Many mothers with GDM had abnormalities of glucose tolerance postpartum (20% type 2 diabetes, 34% impaired glucose tolerance or impaired fasting glucose). Higher cord insulin (57 pmol/l [40-94]) and leptin (26 ng/ml [17-39]) concentrations were found even in offspring of GDM mothers with normal glucose tolerance postpartum.
CONCLUSIONS: Raised cord insulin and leptin concentrations are a common finding in offspring of mothers with type 2 diabetes and GDM in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732019     DOI: 10.2337/dc05-1677

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

Review 1.  The feto-placental endothelium in pregnancy pathologies.

Authors:  Christian Wadsack; Gernot Desoye; Ursula Hiden
Journal:  Wien Med Wochenschr       Date:  2012-05

2.  Neonatal hyperinsulinism secondary to maternal intake of high-sugar drinks.

Authors:  Nicol Jon West; Matthew Thorpe
Journal:  BMJ Case Rep       Date:  2011-07-15

3.  Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study.

Authors:  I-Lynn Lee; Elizabeth L M Barr; Danielle Longmore; Federica Barzi; Alex D H Brown; Christine Connors; Jacqueline A Boyle; Marie Kirkwood; Vanya Hampton; Michael Lynch; Zhong X Lu; Kerin O'Dea; Jeremy Oats; H David McIntyre; Paul Zimmet; Jonathan E Shaw; Louise J Maple-Brown
Journal:  Diabetologia       Date:  2020-01-08       Impact factor: 10.122

Review 4.  Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity.

Authors:  Gernot Desoye; Anthony M Carter
Journal:  Nat Rev Endocrinol       Date:  2022-07-28       Impact factor: 47.564

5.  Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia.

Authors:  Oussama Grissa; Akadiri Yessoufou; Inès Mrisak; Aziz Hichami; Daniel Amoussou-Guenou; Abir Grissa; François Djrolo; Kabir Moutairou; Abdelhedi Miled; Hédi Khairi; Monia Zaouali; Iheb Bougmiza; Aabdelkarim Zbidi; Zouheir Tabka; Naim A Khan
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-09       Impact factor: 3.007

Review 6.  Insulin and the IGF system in the human placenta of normal and diabetic pregnancies.

Authors:  Ursula Hiden; Elisabeth Glitzner; Michaele Hartmann; Gernot Desoye
Journal:  J Anat       Date:  2009-05-07       Impact factor: 2.610

7.  AMPK as Target for Intervention in Childhood and Adolescent Obesity.

Authors:  Joselyn Rojas; Nailet Arraiz; Miguel Aguirre; Manuel Velasco; Valmore Bermúdez
Journal:  J Obes       Date:  2010-12-22

8.  Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium.

Authors:  Francisco Westermeier; Carlos Salomón; Marcelo González; Carlos Puebla; Enrique Guzmán-Gutiérrez; Fredi Cifuentes; Andrea Leiva; Paola Casanello; Luis Sobrevia
Journal:  Diabetes       Date:  2011-04-22       Impact factor: 9.461

9.  Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin.

Authors:  Carlos Salomón; Francisco Westermeier; Carlos Puebla; Pablo Arroyo; Enrique Guzmán-Gutiérrez; Fabián Pardo; Andrea Leiva; Paola Casanello; Luis Sobrevia
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

10.  Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells.

Authors:  Marcelo González; Susana Rojas; Pía Avila; Lissette Cabrera; Roberto Villalobos; Carlos Palma; Claudio Aguayo; Eduardo Peña; Victoria Gallardo; Enrique Guzmán-Gutiérrez; Tamara Sáez; Rocío Salsoso; Carlos Sanhueza; Fabián Pardo; Andrea Leiva; Luis Sobrevia
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.